The Gabelli Healthcare & Wellness Trust (GRX) Fund Overview

The Gabelli Healthcare & Wellness Trust (GRX) Financial Services Profile

The Gabelli Healthcare & Wellness Trust is a closed-end fund specializing in global healthcare and wellness equities. Managed by Gabelli Funds, it offers investors exposure to a diversified portfolio within these sectors. With a focus on companies across all market capitalizations, GRX benchmarks against key S&P indices, providing a dividend yield of 7.08% and operating with a beta of 0.89.

What Is the Investment Thesis for GRX?

The Gabelli Healthcare & Wellness Trust presents an investment opportunity centered on the growing healthcare and wellness sectors. With a dividend yield of 7.08%, GRX offers income potential alongside capital appreciation. The fund's focus on global healthcare and wellness companies provides diversification and exposure to innovative and growing segments of the market. The fund's profit margin of 15.0% indicates operational efficiency. Upcoming catalysts include the aging global population and increasing demand for healthcare services, which are expected to drive growth in the sector. However, potential risks include regulatory changes and market volatility, which could impact the fund's performance. The fund's beta of 0.89 suggests lower volatility compared to the broader market.

Based on FMP financials and quantitative analysis

GRX Key Highlights

Market Cap of $0.14B indicates the size and scale of the fund's investments.

• P/E ratio of 63.45 reflects the valuation of the fund relative to its earnings.
• Profit Margin of 15.0% demonstrates the fund's profitability in its investment activities.
• Gross Margin of 34.2% shows the efficiency of the fund's investment strategies.
• Dividend Yield of 7.08% provides income to investors, making it a noteworthy option for income-seeking investors.

Who Are GRX's Competitors?

GRX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are GRX's Key Strengths?

Experienced management team with expertise in healthcare and wellness investing.

• Global investment strategy providing diversification.
• Closed-end fund structure allowing for long-term investment horizon.
• Attractive dividend yield for income-seeking investors.

What Are GRX's Weaknesses?

Relatively small market capitalization compared to larger asset managers.

• Concentration in the healthcare and wellness sectors, which can be subject to regulatory and market risks.
• Potential for NAV discount compared to underlying asset value.
• Dependence on the performance of the healthcare and wellness sectors.

What Could Drive GRX Stock Higher?

Aging population driving increased demand for healthcare services and products.

• Technological advancements in healthcare creating new investment opportunities.
• Increasing consumer interest in wellness and preventative care.
• Potential for new drug approvals and medical breakthroughs in the healthcare sector.
• Expansion of healthcare services in emerging markets.

What Are the Key Risks for GRX?

Financial-distress signal — its Altman Z-Score of 1.79 sits in the distress zone (elevated bankruptcy risk).

• Rich valuation — a P/E of 63.45 runs well above the Financial Services sector’s ~17.50x, leaving little room for a miss.
• Regulatory changes and healthcare reforms impacting the profitability of healthcare companies.
• Market volatility and economic downturns affecting the performance of equity markets.
• Competition from other asset managers offering similar investment strategies.
• Changes in consumer preferences and trends in the wellness sector.
• Interest rate fluctuations impacting the value of fixed income investments.

What Are the Growth Opportunities for GRX?

• Aging Global Population: The aging global population is a significant growth driver for the healthcare and wellness sectors. As the population ages, the demand for healthcare services, pharmaceuticals, and wellness products increases. This trend is expected to continue over the next several decades, providing a long-term growth opportunity for GRX. The global aging population is estimated to reach over 2 billion by 2050, creating a substantial market for healthcare and wellness companies.
• Technological Advancements in Healthcare: Technological advancements in healthcare, such as telemedicine, digital health, and AI-powered diagnostics, are transforming the industry. These innovations are improving healthcare delivery, reducing costs, and enhancing patient outcomes. GRX can capitalize on this trend by investing in companies that are at the forefront of these technological advancements.
• Increasing Prevalence of Chronic Diseases: The increasing prevalence of chronic diseases, such as diabetes, heart disease, and cancer, is driving demand for healthcare services and products. GRX can benefit from this trend by investing in companies that are developing innovative treatments and therapies for these diseases. The global market for chronic disease management is expected to grow substantially in the coming years, presenting a significant opportunity for GRX.
• Growing Consumer Interest in Wellness: Growing consumer interest in wellness, including fitness, nutrition, and mental health, is creating a large and growing market for wellness products and services. GRX can capitalize on this trend by investing in companies that are catering to this growing demand. The global wellness market is estimated to be worth trillions of dollars, offering a diverse range of investment opportunities.
• Expansion into Emerging Markets: Emerging markets, such as China, India, and Brazil, are experiencing rapid economic growth and increasing access to healthcare. This presents a significant growth opportunity for GRX, as these markets offer untapped potential for healthcare and wellness companies. Investing in these markets can provide GRX with exposure to high-growth opportunities and diversification benefits. The healthcare market in emerging markets is projected to grow at a faster rate than in developed markets, making it an attractive area for investment.

What Are GRX's Competitive Advantages?

• Established brand and reputation of Gabelli Funds.
• Expertise in healthcare and wellness sector investing.
• Global investment strategy providing diversification.
• Closed-end fund structure allowing for long-term investment horizon.

What Does GRX Do?

The Gabelli Healthcare & Wellness Trust (GRX) was established on February 20, 2007, and is domiciled in the United States. As a closed-end equity mutual fund, GRX is managed by Gabelli Funds, LLC, under the umbrella of GAMCO Investors, Inc. The trust's primary investment objective is to seek long-term capital appreciation by investing in a portfolio of companies operating within the healthcare and wellness sectors. This includes pharmaceuticals, biotechnology, medical devices, healthcare services, and companies involved in health and wellness-related consumer products and services. GRX invests across the globe, providing a diversified approach to accessing opportunities in the healthcare and wellness markets. The fund invests in companies across all market capitalizations, from small-cap to large-cap, allowing flexibility in capturing growth potential. The fund's performance is benchmarked against the S&P 500 Index, S&P 500 Consumer Staples Index, and S&P 500 Health Care Index, providing a basis for evaluating its investment strategy and results. GRX aims to deliver value to its shareholders through a combination of capital appreciation and dividend income, reflecting the potential of the healthcare and wellness sectors.

What Products and Services Does GRX Offer?

• Invests in publicly traded companies.
• Focuses on the healthcare sector.
• Targets the wellness sector.
• Operates as a closed-end fund.
• Manages a portfolio of equity securities.
• Seeks long-term capital appreciation.
• Benchmarks performance against S&P indices.

How Does GRX Make Money?

• Generates revenue through investment management fees.
• Earns income from dividends and capital gains from portfolio holdings.
• Utilizes a global investment strategy to identify opportunities.
• Actively manages its portfolio to maximize returns.

What Industry Does GRX Operate In?

The Gabelli Healthcare & Wellness Trust operates within the asset management industry, focusing specifically on the healthcare and wellness sectors. These sectors are experiencing growth driven by factors such as an aging global population, increasing prevalence of chronic diseases, and growing consumer interest in health and wellness. The competitive landscape includes other closed-end funds, ETFs, and mutual funds that focus on healthcare and wellness. GRX differentiates itself through its global investment approach and active management style, seeking to identify undervalued opportunities within these sectors.

Who Are GRX's Key Customers?

• Individual investors seeking exposure to the healthcare and wellness sectors.
• Institutional investors looking for diversified investment opportunities.
• Financial advisors seeking investment solutions for their clients.
• Retirement funds and endowments.

The Gabelli Healthcare & Wellness Trust's Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 1.79 places it in the distress zone, a signal of elevated financial risk.

Return on equity for The Gabelli Healthcare & Wellness Trust stands at 1.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.9%, showing how much profit it generates from its asset base. GRX trades at a trailing price-to-earnings ratio of 63.45, above the Financial Services sector average of ~17.50x. Its free cash flow yield is 6.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.03 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 1.6%, the inverse of the P/E and a quick read on earnings relative to price.

GRX Revenue & Earnings Trend

In Q4 FY2025, GRX generated $6.4M in top-line revenue, marking a sequential decrease of 27.5%. The company recorded net income of $3.8M, with diluted EPS of $0.25. Quarter-over-quarter revenue has been mixed, typical for a unknown company operating in Financial Services. Across the four most recent quarters, GRX averaged $0.03 in diluted EPS.

Over the past six months, The Gabelli Healthcare & Wellness Trust insiders filed 6 SEC Form 4 transactions — 0 sales and 6 purchases. On net that is roughly 37K shares acquired (about $378K) — insiders putting money in tends to read as conviction.

GRX Financials

GRX Latest News

GRX Analyst Consensus

GRX MoonshotScore

The Gabelli Healthcare & Wellness Trust Financial Services Stock: Key Questions Answered

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources